Hubei Hongyuan Pharmaceutical Technology (301246.SZ) supervisors Duan Xiaoliu and Lei Gaoliang have completed their share reduction period and collectively reduced their holdings by 1.1 million shares.
Hongyuan Pharmaceutical Co., Ltd. (301246.SZ) announced that the term of the company supervisors Duan Xiaoliu and Lei Gaoliang's reduction plan has expired, with a total...
Announcement from Hubei Hongyuan Pharmaceutical Technology (301246.SZ): The term of the reduction plan for the supervisors Duan Xiaoliu and Lei Gaoliang has expired, with a total reduction of 1.1 million shares in the company.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
